• Register
  • Login
  • Subscribe
  • Contact Us

Medicinal Product for Autologous Cell Therapy - Lisokabtagen Maralacel - 2025

CzechRepublicTenders notice for Medicinal Product for Autologous Cell Therapy - Lisokabtagen Maralacel - 2025. The reference ID of the tender is 128113033 and it is closing on 14 Nov 2025.

Tender Details

  • Country: Czech Republic
  • Summary: Medicinal Product for Autologous Cell Therapy - Lisokabtagen Maralacel - 2025
  • CZT Ref No: 128113033
  • Deadline: 14 Nov 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: CZK 138400000
  • Notice Type: Tender
  • Document Ref. No.: 674102-2025
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • The subject of the public contract is the supply of a medicinal product intended for the therapy of malignant blood diseases in the total expected volume of 16 individual doses of the medicinal product.
    implemented on the basis of the results of the completed tender for four years after the signing of the purchase contract.
    maleucel
    Car-positive viable CD8+ T-lymphocytes / bottle containing cellular dispersion 5.1-322 x 10⁶ Car-positive CD4+ T-lymphocytes. The expected annual volume is 4 doses, each corresponding to the amount of drug administered to one patient according to their individual need (one or more inj. vials in a specific ratio), ATC L01XL08.
    The patient based on his current needs, regardless of the number/type of form administered.
    Sukl. SUKL registration is a necessary condition for the standard use of medicinal products within the provision of health care pursuant to Section 8 (1) of Act No. 378/2007 Coll. pro...
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Medicinal Product for Autologous Cell Therapy - Lisokabtagen Maralacel - 2025 - Czech Republic Tender

The UNIVERSITY HOSPITAL PILSEN, a Government sector organization in Czech Republic, has announced a new tender for Medicinal Product for Autologous Cell Therapy - Lisokabtagen Maralacel - 2025. This tender is published on CzechRepublicTenders under CZT Ref No: 128113033 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-14.

The estimated tender value is CZK 138400000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

CzechRepublicTenders Features

CzechRepublicTenders Features

Fresh and verified Tenders from Czech Republic. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting CzechRepublicTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Czech Republic in your email inbox.

  Chat with us